HEALTHCARE & PHARMACEUTICALS MARKET RESEARCH
Category: SARS-Cov2
Virology
-
FIRST DEATH FOLLOWING COVID-19 VACCINATION
A 68 year old man has died after being fully vaccinated with the covishield vaccine in the month of March due to anaphylaxis, which is considered as a severe allergic…
-
HOW LIKELY IS THE THIRD WAVE IN INDIA?
Several speculations are doing the rounds regarding the possibility of a third wave and if children are at a risk of getting infected in the subsequent wave. There is a…
-
Concern of rising SARS-CoV2 Variants and Mutations
As new variants of SARS-Cov2 the official title given to the COVID-19 virus, continue to arise, similar transformations are discovered by the scientists, making the infection more problematic and destructive….
-
GOVERNMENT TO RESERVE 30 CRORE DOSES OF BIOLOGICAL E’S NEW VACCINE
Biological E, a Hyderabad-based vaccine and pharmaceutical company, has announced that it has successfully completed the Phase I/II clinical trial of its COVID-19 subunit vaccine candidate in India called Corbevax…
-
NEW COVID TREATMENT IN INDIA: ANTIBODY COCKTAIL BY ROCHE AND CIPLA
The monoclonal antibody cocktail, effective against the B.1.617 variant (found in India) is being imported by Roche, a Switzerland-based leading healthcare company and marketed in India through Cipla Ltd has…
-
MUCORMYCOSIS(BLACK FUNGUS) : AN EPIDEMIC WITHIN A PANDEMIC
Also known as black fungus, mucormycosis is a rare and invasive systemic fungal infection that occurs due to exposure to mucor mould that may be present in plants, air, soil,…
-
Everything you should know about 2-DG : DRDO’S exciting new anti-COVID drug
Everything you need to know about 2-DG : DRDO’S new anti-COVID drug
-
NEW AUSTRALIAN COVID VACCINE TO COMPLETELY PREVENT COVID-19 TRANSMISSION
An Adelaide based company, Vaxine Pty Ltd has successfully developed a COVID vaccine, COVAX-19 that holds the ability to completely prevent the covid-19 virus transmission in non-immune individuals. No other…
Follow Us
Recent Posts
-
Bedaquiline Role in Treating Tuberculosis having a hefty $1.38 billion dollar market
-
Adalimumab’s competition and immense market Growth Potential of 5.1%
-
Semaglutide’s massive influence on the Diabetes Pharmaceutical Market and 6 competitors
-
FDA approved Leqembi to have $12.9 billion sales
-
Assistive Technology Market; a $82B Growth Story
Tags
Autoimmunity cancer cancer research cancer therapy CDSCO covid-19 covid in children Diabetes drug Elderly Health FDA healthcare immune response Kerala mutations Nipah virus pandemic PCOS pharma Pharmaceutical market pharma sector protein-based vaccines sars-cov-2 therapy third wave Treatment vaccine variants WHO zydus cadila